Literature DB >> 19931023

Adjuvant radiotherapy for gastric cancer: A dosimetric comparison of 3-dimensional conformal radiotherapy, tomotherapy and conventional intensity modulated radiotherapy treatment plans.

Max Dahele1, Matthew Skinner, Brenda Schultz, Marlene Cardoso, Chris Bell, Yee C Ung.   

Abstract

Some patients with gastric cancer benefit from post-operative chemo-radiotherapy, but adequately irradiating the planning target volume (PTV) whilst avoiding organs at risk (OAR) can be difficult. We evaluate 3-dimensional conformal radiotherapy (CRT), conventional intensity-modulated radiotherapy (IMRT) and helical tomotherapy (TT). TT, 2 and 5-field (F) CRT and IMRT treatment plans with the same PTV coverage were generated for 5 patients and compared. Median values are reported. The volume of left/right kidney receiving at least 20Gy (V20) was 57/51% and 51/60% for 2 and 5F-CRT, and 28/14% for TT and 27/19% for IMRT. The volume of liver receiving at least 30Gy (V30) was 45% and 62% for 2 and 5F-CRT, and 37% for TT and 35% for IMRT. With TT, 98% of the PTV received 95-105% of the prescribed dose, compared with 45%, 34% and 28% for 2F-CRT, 5F-CRT and IMRT respectively. Using conventional metrics, conventional IMRT can achieve comparable PTV coverage and OAR sparing to TT, but at the expense of PTV dose heterogeneity. Both irradiate large volumes of normal tissue to low doses. Additional studies are needed to demonstrate the clinical impact of these technologies. 2010 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19931023     DOI: 10.1016/j.meddos.2009.03.003

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  10 in total

Review 1.  Proton beam therapy for gastrointestinal cancers: past, present, and future.

Authors:  Shahed N Badiyan; Christopher L Hallemeier; Steven H Lin; Matthew D Hall; Michael D Chuong
Journal:  J Gastrointest Oncol       Date:  2018-10

2.  Image-guided intensity-modulated radiotherapy for patients with locally advanced gastric cancer: a clinical feasibility study.

Authors:  Harun Badakhshi; Arne Gruen; Reinhold Graf; Dirk Boehmer; Volker Budach
Journal:  Gastric Cancer       Date:  2013-10-11       Impact factor: 7.370

3.  Dosimetric comparison of 3-dimensional conformal radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for postoperative gastric cancer patients.

Authors:  Cem Onal; Yemliha Dölek; Berna Akkuş Yıldırım
Journal:  Jpn J Radiol       Date:  2017-11-03       Impact factor: 2.374

Review 4.  Postoperative chemoradiotherapy vs. preoperative chemoradiotherapy for locally advanced (operable) gastric cancer: clarifying the role and technique of radiotherapy.

Authors:  Rebecca K S Wong; Raymond Jang; Gail Darling
Journal:  J Gastrointest Oncol       Date:  2015-02

5.  Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy.

Authors:  Xin Wang; Yuan Tian; Yuan Tang; Zhi-Hui Hu; Jia-Jia Zhang; Gui-Shan Fu; Pan Ma; Hua Ren; Tao Zhang; Ning Li; Wen-Yang Liu; Hui Fang; Ye-Xiong Li; Jing Jin
Journal:  Oncotarget       Date:  2017-06-13

6.  IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer.

Authors:  Shalini Moningi; Jaffer A Ajani; Brian D Badgwell; Mariela B Murphy; Naruhiko Ikoma; Paul F Mansfield; Jennifer C Ho; Yelin Suh; Christopher Crane; Joseph M Herman; Emma B Holliday; Eugene Koay; Albert C Koong; Sunil Krishnan; Bruce Minsky; Grace Smith; Cullen Taniguchi; Prajnan Das
Journal:  Adv Radiat Oncol       Date:  2019-11-28

Review 7.  Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy.

Authors:  Daniel Buergy; Frank Lohr; Tobias Baack; Kerstin Siebenlist; Stefan Haneder; Henrik Michaely; Frederik Wenz; Judit Boda-Heggemann
Journal:  Radiat Oncol       Date:  2012-11-16       Impact factor: 3.481

8.  Dosimetric comparison of intensity modulated and volumetric arc radiation therapy for gastric cancer.

Authors:  Zhiping Li; Jianshuang Zeng; Zi Wang; Hong Zhu; Yuquan Wei
Journal:  Oncol Lett       Date:  2014-07-18       Impact factor: 2.967

9.  Prediction of radiosensitive patients with gastric cancer by developing gene signature.

Authors:  Jin Zhou; Xiaoyu Wu; Gang Li; Xin Gao; Min Zhai; Weichang Chen; Huagang Hu; Zaixiang Tang
Journal:  Int J Oncol       Date:  2017-08-30       Impact factor: 5.650

Review 10.  The necessity of adjuvant radiotherapy for locally advanced gastric cancer in China.

Authors:  Yongqiang Yang; Pengfei Xing; Ning Zhou; Yongyou Wu; Liyuan Zhang; Ye Tian
Journal:  Transl Cancer Res       Date:  2019-04       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.